Information  X 
Enter a valid email address

Company Name matching 'HELSINN Healthcare SA'

Date
Time Source
Company
Announcement
14 Nov 2019 8:00 am GNW   Helsinn Healthcare S.A. Helsinn supported ‘70 Years of Cancer Care in China’ celebratory event in Shanghai
09 Oct 2019 10:00 am GNW   Helsinn Healthcare S.A. Helsinn to co-host MF-CTCL satellite symposium alongside Recordati Rare Diseases at the EADV 2019 Congress GNW: European only
26 Sep 2019 1:54 pm GNW   Helsinn Healthcare S.A. Helsinn demonstrates commitment to MF CTCL with multiple scientific sessions at the EORTC Cutaneous Lymphoma Meeting 2019
  11:35 am GNW   Helsinn Healthcare S.A. Helsinn announces abstract accepted for oral presentation at the EORTC Cutaneous Lymphoma Meeting 2019
19 Sep 2019 9:00 am GNW   Helsinn Healthcare S.A. Helsinn and Recordati Rare Diseases to announce satellite symposium on advances in Mycosis Fungoides-Cutaneous T cell Lymphoma
17 Sep 2019 1:10 pm GNW   Helsinn Healthcare S.A. Helsinn and Lyfebulb Announce Call for Applications for Third Annual Patient-Driven Innovation Summit & Award in Oncology
16 Sep 2019 7:00 am GNW   Helsinn Healthcare S.A. Helsinn and Mundipharma China Pharmaceutical jointly announce NMPA’s approval of the oral formulation of Akynzeo® in China
29 Aug 2019 1:00 pm GNW   Helsinn Healthcare S.A. Helsinn and Lyfebulb Announce Third Annual Patient-Driven Innovation Summit & Award in Oncology to be held during the 14th Monaco Biennale of Oncology 2020
31 Jul 2019 1:10 pm GNW   Helsinn Healthcare S.A. Helsinn and Endo Announce Agreement for Paladin Labs Inc. to Commercialize Pracinostat in Canada
15 Jul 2019 3:05 pm GNW   Helsinn Healthcare S.A. Helsinn Investment Fund Announces First Exit
26 Jun 2019 6:00 am GNW   Helsinn Healthcare S.A. Helsinn appoints Giorgio Calderari, Group General Manager and Chief Operating Officer, to the Board of Directors
12 Jun 2019 8:30 am GNW   Helsinn Healthcare S.A. Helsinn to co-support a satellite symposium on current and emerging treatments of Acute Myeloid Leukemia (AML) at 24th European Hematology Association (EHA) Congress
07 Jun 2019 8:00 am GNW   Helsinn Healthcare S.A. Helsinn Group supports two events with the International Society for Cutaneous Lymphomas (ISCL) at the 24th World Congress of Dermatology
01 Jun 2019 1:00 pm GNW   Helsinn Healthcare S.A. Conquer Cancer Foundation/Anna Braglia Endowed Young Investigator Award (YIA) in Cancer Supportive Care, supported by Helsinn, awarded to Dr. Allison Barz Leahy, MD, University of Pennsylvania
31 May 2019 1:00 pm GNW   Helsinn Healthcare S.A. Helsinn Group Announces Upcoming Presentation of Phase 3b data of NEPA (fosnetupitant / palonosetron) IV at ASCO 2019
09 May 2019 8:00 am GNW   Helsinn Healthcare S.A. Helsinn and Mundipharma China Pharmaceutical together announce the launch of ALOXI® IV in China and a Co-Detailing collaboration in Shanghai
07 May 2019 4:19 pm GNW   Helsinn Healthcare S.A. Helsinn nominated as a Swiss Biotech Success Story 2019/2020 by the Swiss Biotech Association
19 Mar 2019 10:00 pm GNW   Helsinn Healthcare S.A. Winners of the second annual Lyfebulb-Helsinn Innovation Summit & Awards in Oncology announced
07 Mar 2019 8:00 am GNW   Helsinn Healthcare S.A. Helsinn initiates two new global Phase III studies with anamorelin
27 Feb 2019 1:15 pm GNW   Helsinn Healthcare S.A. Helsinn Investment Fund: Ten finalists have been chosen for the second annual Lyfebulb-Helsinn Innovation Summit & Awards in Oncology
19 Feb 2019 7:30 am GNW   Helsinn Healthcare S.A. Helsinn Investment Fund Invests €1 Million in Gain Therapeutics
14 Feb 2019 8:22 pm GNW   Helsinn Healthcare S.A. Helsinn and MEI Pharma Announce Publication of Phase II Data for Pracinostat in Combination with Azacitidine in Blood Advances
31 Jan 2019 8:00 am GNW   Helsinn Healthcare S.A. Helsinn Provides Educational Grant for ESMO’s Preceptorship for Supportive and Palliative Care
21 Dec 2018 1:00 pm GNW   Helsinn Healthcare S.A. Helsinn Group Grants Exclusive Licensing Rights to Menarini for Pracinostat
20 Dec 2018 7:45 am GNW   Helsinn Healthcare S.A. RECORDATI AND HELSINN AGREEMENT FOR THE EXCLUSIVE COMMERCIALIZATION RIGHTS TO LEDAGA®
12 Dec 2018 1:00 pm GNW   Helsinn Healthcare S.A. Helsinn Group Announces new Permanent J Code for AKYNZEO® (fosnetupitant and palonosetron) for injection in the US
03 Dec 2018 5:30 pm GNW   Helsinn Healthcare S.A. Phase 2 Interim Data Evaluating the Combination of Pracinostat and Azacitidine in Patients with Myelodysplastic Syndrome Presented at the 2018 American Society of Hematology Annual Meeting
  6:15 am GNW   Helsinn Healthcare S.A. Helsinn and Mundipharma China Pharmaceutical Announce Approval of ALOXI® IV by the National Medical Products Administration (NMPA)
27 Nov 2018 3:52 pm GNW   Helsinn Healthcare S.A. Helsinn and Lyfebulb Announce Partnership for Second Annual Patient-Driven Innovation Summit in Cancer
06 Nov 2018 8:00 am GNW   Helsinn Healthcare S.A. Helsinn Group supports Satellite Symposium at 14th EADO Congress 2018
01 Oct 2018 10:05 am GNW   Helsinn Healthcare S.A. Helsinn Group strengthens the Board with the appointment of Francesco Granata
26 Sep 2018 9:00 am GNW   Helsinn Healthcare S.A. Helsinn Group supports Satellite Symposium at EORTC CLTF 2018 Annual Meeting
15 Aug 2018 11:30 am GNW   Helsinn Healthcare S.A. Mundipharma brings its cancer supportive care expertise to Vietnam after signing agreement with Helsinn Group for ALOXI® (palonosetron HCl) 
31 Jul 2018 9:00 am GNW   Helsinn Healthcare S.A. Helsinn and CJ Healthcare announce the approval of AKYNZEO® oral formulation in Korea
26 Jun 2018 9:00 am GNW   Helsinn Healthcare S.A. Helsinn Group and Angelini support Satellite Symposium at MASCC/ISOO 2018 Annual Meeting
30 May 2018 8:00 am GNW   Helsinn Healthcare S.A. Helsinn Group and MEI Pharma Announce Upcoming Presentation at ASCO 2018 on the design of the Phase III PRIMULA study of Pracinostat in combination with azacitidine for the treatment of Acute Myeloid Leukemia (AML) in adult patients unfit f
08 May 2018 1:30 pm GNW   Helsinn Healthcare SA Helsinn Group announces the launch of the IV formulation of AKYNZEO® (fosnetupitant/palonosetron) in the United States
20 Apr 2018 2:23 pm GNW   Helsinn Healthcare SA Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO® (fosnetupitant/ palonosetron) in the United States
16 Apr 2018 7:00 am GNW   Helsinn Healthcare SA Taiho Pharmaceutical and Helsinn Group present preclinical data at AACR Annual Meeting for a RET inhibitor under co-development as an attractive compound for anticancer therapy
28 Mar 2018 1:00 pm GNW   Helsinn Healthcare SA Helsinn Healthcare S.A.: Winners of the inaugural Lyfebulb-Helsinn Innovation Summit & Awards in Oncology announced
01 Mar 2018 1:35 pm GNW   Helsinn Healthcare SA Helsinn Healthcare S.A.: Eleven finalists have been chosen for the first ever Lyfebulb-Helsinn Innovation Summit & Award in Oncology
09 Jan 2018 1:30 pm GNW   Helsinn Healthcare SA Helsinn Healthcare S.A.: A call for action to patient entrepreneurs in the area of cancer to compete at the Lyfebulb-Helsinn Summit for the first ever Lyfebulb- Helsinn Innovation Award
10 Oct 2017 7:30 am GNW   Helsinn Healthcare SA Helsinn announces its support for the International Fellowship Program (IFP), a joint project founded by the Society for Translational Oncology (STO) and Chinese Society of Clinical Oncology (CSCO)
05 Sep 2017 1:15 pm GNW   Helsinn Healthcare SA Helsinn Therapeutics (U.S.) Inc., Signs Co-Promotion Agreement for Cancer Therapeutic Zykadia® in the US
30 Jun 2009 1:52 pm PRN   Helsinn Healthcare SA Supportive Care in Cancer: Palonosetron Recomme...
22 Jun 2009 11:00 am PRN   Helsinn Healthcare SA Helsinn Announces New Plans for its Manufacturi...
05 Jun 2009 9:00 am PRN   Helsinn Healthcare SA Single Dose Palonosetron Prevents Emesis Induce...
02 Apr 2009 5:05 pm PRN   Helsinn Healthcare SA Helsinn and Tánaiste Announce new R&D Cent...
28 Jan 2009 6:01 pm PRN   Helsinn Healthcare SA Helsinn Announces the Acquisition of Sapphire T...
11 Dec 2008 7:00 am PRN   Helsinn Healthcare SA Helsinn Birex Pharmaceuticals Receives IMP Lice...
27 Nov 2008 9:00 am PRN   Helsinn Healthcare SA Helsinn Healthcare and Zealand Pharma Sign a Pa...
09 Jul 2008 11:54 am PRN   Helsinn Healthcare SA Helsinn Healthcare SA Announces the Launch of A...
03 Mar 2008 5:45 pm PRN   Helsinn Healthcare SA FDA Approves Aloxi(R) (Palonosetron HCl) Inject...
13 Feb 2008 11:00 am PRN   Helsinn Healthcare SA Helsinn Healthcare SA and Riemser Arzneimittel ...
03 Jan 2008 5:00 pm PRN   Helsinn Healthcare SA Helsinn and MGI Pharma Announce sNDA for Aloxi ...
30 Oct 2007 11:47 am PRN   Helsinn Healthcare SA Helsinn Healthcare and MGI PHARMA Announce Subm...
10 Jul 2007 1:30 pm PRN   HELSINN Healthcare SA HELSINN Announces Aloxi sNDA for PONV Accepted ...


Company Announcements Archive »

 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t